Reynosin protects against neuronal toxicity in dopamine-induced SH-SY5Y cells and 6-hydroxydopamine-lesioned rats as models of Parkinson's disease: Reciprocal up-regulation of E6-AP and down-regulation of α-synuclein

Brain Research

Volumn 1524, Issue , 2013, Pages 54-61

  Ham, Ahrom ^a   Kim, Dong Woo ^a   Kim, Kyeong Ho ^b   Lee, Sung Jin ^b   Oh, Ki Bong ^a   Shin, Jongheon ^a   Mar, Woongchon ^a  

^a Seoul National University   (South Korea)

^b Kangwon National University   (South Korea)

Author keywords

Synuclein; 6 OHDA lesion; E6 associated protein; Neuroprotection; Parkinson's disease; Reynosin

Indexed keywords

ALPHA SYNUCLEIN; DOPAMINE; E6 ASSOCIATED PROTEIN; OXIDOPAMINE; REYNOSIN; SESQUITERPENE LACTONE DERIVATIVE; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DEATH; CHEMICAL STRUCTURE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOWN REGULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; LAURUS NOBILIS; NEUROBLASTOMA CELL; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SUBSTANTIA NIGRA; UPREGULATION; WESTERN BLOTTING;

Α-SYNUCLEIN; 6-OHDA LESION; E6-ASSOCIATED PROTEIN; NEUROPROTECTION; PARKINSON'S DISEASE; REYNOSIN;

ALPHA-SYNUCLEIN; ANIMALS; BLOTTING, WESTERN; CELL DEATH; CELL LINE; DOWN-REGULATION; FLOW CYTOMETRY; HUMANS; MALE; NEURONS; NEUROPROTECTIVE AGENTS; PARKINSONIAN DISORDERS; RATS; RATS, SPRAGUE-DAWLEY; SESQUITERPENES; UBIQUITIN-PROTEIN LIGASES; UP-REGULATION;

RATTUS; RODENTIA;

EID: 84880332127     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2013.05.036     Document Type: Article

References (38)

1. M.T. Armentero Prolonged blockade of NMDA or mGluR5 glutamate receptors reduces nigrostriatal degeneration while inducing selective metabolic changes in the basal ganglia circuitry in a rodent model of Parkinson's disease Neurobiol. Dis. 22 2006 1 9
2. M. Asanuma, I. Miyazaki, and N. Ogawa Dopamine- or l-DOPA-induced neurotoxicity: the role of dopamine quinone formation and tyrosinase in a model of Parkinson's disease Neurotoxic. Res. 5 2003 165 176
3. A. Barzilai, E. Melamed, and A. Shirvan Is there a rationale for neuroprotection against dopamine toxicity in Parkinson's disease? Cell Mol. Neurobiol. 21 2001 215 235
4. M.C. Bennett The role of alpha-synuclein in neurodegenerative diseases Pharmacol. Ther. 105 2005 311 331
5. F. Blandini Neuroprotective effect of rasagiline in a rodent model of Parkinson's disease Exp. Neurol. 187 2004 455 459
6. Y. Chu Nurr1 in Parkinson's disease and related disorders J. Comp. Neurol. 494 2006 495 514
7. Y. Chu, and J.H. Kordower Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: is this the target for Parkinson's disease? Neurobiol. Dis. 25 2007 134 149
8. K.A. Conway Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct Science 294 2001 1346 1349
9. V.N. Dedov, G.C. Cox, and B.D. Roufogalis Visualisation of mitochondria in living neurons with single- and two-photon fluorescence laser microscopy Micron 32 2001 653 660
10. M.B. Feany, and W.W. Bender A drosophila model of Parkinson's disease Nature 404 2000 394 398
11. H.S. Foyet Methanolic extract of Hibiscus asper leaves improves spatial memory deficits in the 6-hydroxydopamine-lesion rodent model of Parkinson's disease J. Ethnopharmacol. 133 2011 773 779
12. T.E. Golde The therapeutic importance of understanding mechanisms of neuronal cell death in neurodegenerative disease Mol. Neurodegener. 4 2009 8
13. C. Gomez-Santos Dopamine induces autophagic cell death and alpha-synuclein increase in human neuroblastoma SH-SY5Y cells J. Neurosci. Res. 73 2003 341 350
14. C. Gomez-Santos Induction of C/EBP beta and GADD153 expression by dopamine in human neuroblastoma cells. Relationship with alpha-synuclein increase and cell damage Brain Res. Bull. 65 2005 87 95
15. A. Ham Spirafolide from bay leaf (Laurus nobilis) prevents dopamine-induced apoptosis by decreasing reactive oxygen species production in human neuroblastoma SH-SY5Y cells Arch. Pharm. Res. 33 2010 1953 1958
16. H. Hara, M. Ohta, and T. Adachi Apomorphine protects against 6-hydroxydopamine-induced neuronal cell death through activation of the Nrf2-ARE pathway J. Neurosci. Res. 84 2006 860 866
17. A.J. Hughes Subcutaneous apomorphine in Parkinson's disease: response to chronic administration for up to five years Mov. Disord. 8 1993 165 170
18. R. Iancu Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice Behav. Brain Res. 162 2005 1 10
19. Y.H. Jiang, and A.L. Beaudet Human disorders of ubiquitination and proteasomal degradation Curr. Opin. Pediatr. 16 2004 419 426
20. S. Kanda Enhanced vulnerability to oxidative stress by alpha-synuclein mutations and C-terminal truncation Neuroscience 97 2000 279 284
21. D. Kirik Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system J. Neurosci. 22 2002 2780 2791
22. E. Masliah Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders Science 287 2000 1265 1269
23. M.J. Millan Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes J. Pharmacol. Exp. Ther. 303 2002 791 804
24. A. Mishra E6-AP promotes misfolded polyglutamine proteins for proteasomal degradation and suppresses polyglutamine protein aggregation and toxicity J. Biol. Chem. 283 2008 7648 7656
25. A. Mishra The ubiquitin ligase E6-AP is induced and recruited to aggresomes in response to proteasome inhibition and may be involved in the ubiquitination of Hsp70-bound misfolded proteins J. Biol. Chem. 284 2009 10537 10545
26. A. Mishra E6-AP association promotes SOD1 aggresomes degradation and suppresses toxicity Neurobiol. Aging 34(4) 1310 2013 e11 e23
27. I. Miyazaki, and M. Asanuma Dopaminergic neuron-specific oxidative stress caused by dopamine itself Acta Med. Okayama 62 2008 141 150
28. S.A. Mulherkar, J. Sharma, and N.R. Jana The ubiquitin ligase E6-AP promotes degradation of alpha-synuclein J. Neurochem. 110 2009 1955 1964
29. A. Nicotra, and S. Parvez Apoptotic molecules and MPTP-induced cell death Neurotoxicol. Teratol. 24 2002 599 605
30. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates 1998 Academic Press San Diego
31. M. Scheffner Ubiquitin, E6-AP, and their role in p53 inactivation Pharmacol. Ther. 78 1998 129 139
32. W.W. Smith Alpha-synuclein phosphorylation enhances eosinophilic cytoplasmic inclusion formation in SH-SY5Y cells J. Neurosci. 25 2005 5544 5552
33. S. Srinivasan, and Z. Nawaz E3 ubiquitin protein ligase, E6-associated protein (E6-AP) regulates PI3K-Akt signaling and prostate cell growth Biochim. Biophys. Acta 1809 2011 119 127
34. U. Ungerstedt 6-Hydroxy-dopamine induced degeneration of central monoamine neurons Eur. J. Pharmacol. 5 1968 107 110
35. H. Watanabe Protective effects of neuronal nitric oxide synthase inhibitor in mouse brain against MPTP neurotoxicity: an immunohistological study Eur. Neuropsychopharmacol. 14 2004 93 104
36. F. Yang Role of autophagy and proteasome degradation pathways in apoptosis of PC12 cells overexpressing human alpha-synuclein Neurosci. Lett. 454 2009 203 208
37. M. Yoshikawa Alcohol absorption inhibitors from bay leaf (Laurus nobilis): structure-requirements of sesquiterpenes for the activity Bioorg. Med. Chem. 8 2000 2071 2077
38. H. Yuan R-apomorphine protects against 6-hydroxydopamine-induced nigrostriatal damage in rat Neurosci. Bull. 22 2006 331 338